AM Biotech of South Korea - Market Awareness Study of Female Cervical Cancer Preventive Care Products
Company overview
AM Biotech, a South Korean biotechnology company, is a specialized enterprise focused on biomedical R&D and technological innovation, with long-term commitment to women's health. The company is dedicated to translating cutting-edge medical technologies into effective and safe consumer health products. AM Biotech operates multiple offices in China, providing extensive product promotion and technical services to meet the growing demand for women's health management.
Research background
With the increasing availability of HPV vaccines among Chinese women, awareness of female health protection has strengthened, and preventive care has emerged as a new demand in health management. AM Biotech, based on market trends and user insights, has introduced an innovative concept for preventive cervical cancer care products. To validate the market acceptance of this product concept, identify the core user group and their specific needs, and guide future R&D and market entry strategies, the company has commissioned a dedicated consumer research study.
Research scope
In November 2019, CEIDEA Research was engaged by AM Biotech to conduct a specialized study on female consumers' behaviors, perceptions, and acceptance of cervical health care products. The research employed a mixed-method approach combining online questionnaires and offline in-depth interviews, targeting women aged 25 to 40 in first and second-tier cities. The study focused on understanding their HPV vaccine uptake behaviors, knowledge of cervical cancer, awareness of preventive measures, current usage and pain points related to existing personal care products, and the potential acceptance of a 'preventive cervical care' product concept. It further assessed user acceptance levels, price sensitivity, brand preferences, and preferred purchasing channels, ultimately generating a detailed profile of the core target audience and analyzing their specific needs and usage scenarios.
Expected outcomes
This study will help AM Biotech clarify the current awareness and behavioral patterns of female consumers regarding cervical health care products, evaluate the market competitiveness of the product concept, and define the structure and segmentation of the consumer base. The research findings will provide precise data support for product positioning, feature development, pricing strategy, marketing communication direction, and channel planning, enabling AM Biotech to achieve differentiated market breakthrough in the women's health niche segment.
Scan to add our research consultant